Terumo Stock Price, News & Analysis
Company Description
Terumo (OTC Link: TRUMF) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $25.7B.
TRUMF stock has declined 26.8% over the past year. Shares last traded at $13.09.
This page provides a comprehensive overview of TRUMF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Terumo (TRUMF) stock last traded at $13.09. Over the past 12 months, the stock has lost 26.8%. At a market capitalization of $25.7B, TRUMF is classified as a large-cap stock with approximately 1.5B shares outstanding.
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Terumo (TRUMF) currently stands at 760.1 thousand shares, down 50.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 82%. This relatively low short interest suggests limited bearish sentiment. With 286.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Terumo (TRUMF) currently stands at 286.3 days, up 1936.1% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 14.1 to 1000.0 days.
TRUMF Company Profile & Sector Positioning
Terumo (TRUMF) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing TRUMF often look at related companies in the same sector, including Terumo Corp (TRUMY), Sartorius Stedim (SDMHF), Straumann Hlding (SAUHY), Sartorius (SOAGY), and Sartorius (SARTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TRUMF's relative position within its industry.